Page last updated: 2024-10-23

bisindolylmaleimide i and Cystic Fibrosis

bisindolylmaleimide i has been researched along with Cystic Fibrosis in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breuer, W1
Glickstein, H1
Kartner, N1
Riordan, JR1
Ausiello, DA1
Cabantchik, IZ1

Other Studies

1 other study available for bisindolylmaleimide i and Cystic Fibrosis

ArticleYear
Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells.
    The Journal of biological chemistry, 1993, Jul-05, Volume: 268, Issue:19

    Topics: Adenocarcinoma; Colonic Neoplasms; Cycloheximide; Cystic Fibrosis; Cystic Fibrosis Transmembrane Con

1993